XASXDEM
Market cap23mUSD
Jan 09, Last price
0.13AUD
1D
0.00%
1Q
-7.14%
Jan 2017
-99.65%
IPO
-68.14%
Name
De.mem Ltd
Chart & Performance
P/E
—
P/S
1.63
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
17.88%
Rev. gr., 5y
17.34%
Revenues
23m
+19.16%
Net income
-3m
L-10.25%
CFO
-1m
L-23.13%
Earnings
Mar 03, 2025
Profile
De.mem Limited designs, builds, owns, and operates de-centralized water and wastewater treatment systems for its customers in industrial, municipal, and residential sectors primarily in Australia, Singapore, and Germany. The company offers disinfection systems, such as chlorination and ultraviolet systems; biological treatments that include aerobic and anaerobic treatments; chemical dosing systems and chemical treatments; membrane-based water treatment systems, including microfiltration, ultrafiltration, hollow fiber nanofiltration, reverse osmosis, membrane bioreactors, and hollow fire forward osmosis; and other specialized treatment processes, such as dissolved air filtration, media filtration, and ion exchange. It also provides programmable logic controller and automation solutions; and sludge management services. In addition, the company offers potable water supply, sewage treatment, industrial wastewater, recycling, desalination, and process water solutions. Further, it provides operation and maintenance of water or wastewater treatment systems; consulting, engineering, and optimization services; technical advisory services; and build, own, and operate/build, own, operate, and transfer services. The company serves mining, infrastructure, electronics, chemicals, oil and gas, and food and beverage industries. De.mem Limited was founded in 2013 and is based in Melbourne, Australia.
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2016‑06 | 2015‑12 | |
| Income | ||||||||||
Revenues | 23,407 19.16% | 19,644 8.66% | ||||||||
Cost of revenue | 24,867 | 23,390 | ||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | (1,460) | (3,746) | ||||||||
NOPBT Margin | ||||||||||
Operating Taxes | 15 | 43 | ||||||||
Tax Rate | ||||||||||
NOPAT | (1,475) | (3,789) | ||||||||
Net income | (3,134) -10.25% | (3,492) -21.93% | ||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | 2,488 | |||||||||
BB yield | -9.36% | |||||||||
| Debt | ||||||||||
Debt current | 753 | 509 | ||||||||
Long-term debt | 2,444 | 1,772 | ||||||||
Deferred revenue | 630 | 630 | ||||||||
Other long-term liabilities | 34 | 107 | ||||||||
Net debt | 629 | (3,160) | ||||||||
| Cash flow | ||||||||||
Cash from operating activities | (1,446) | (1,881) | ||||||||
CAPEX | (599) | (1,769) | ||||||||
Cash from investing activities | (728) | (3,971) | ||||||||
Cash from financing activities | (485) | 2,323 | ||||||||
FCF | (2,313) | (4,865) | ||||||||
| Balance | ||||||||||
Cash | 2,468 | 5,391 | ||||||||
Long term investments | 100 | 50 | ||||||||
Excess cash | 1,398 | 4,459 | ||||||||
Stockholders' equity | 11,573 | 14,315 | ||||||||
Invested Capital | 12,487 | 11,985 | ||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | 245,064 | 231,148 | ||||||||
Price | 0.12 0.00% | 0.12 -48.89% | ||||||||
Market cap | 28,182 6.02% | 26,582 -42.91% | ||||||||
EV | 28,811 | 23,422 | ||||||||
EBITDA | 353 | (2,133) | ||||||||
EV/EBITDA | 81.62 | |||||||||
Interest | 75 | 98 | ||||||||
Interest/NOPBT | ||||||||||